Cerebral Embolic Protection Device During TAVR
NCT: NCT07627984 · COMPLETED
NCT IDNCT07627984
StatusCOMPLETED
Start Date2023-09-20
Completion2025-04-16
SponsorShanghai Shenqi Medical Technology Co., Ltd (INDUSTRY)
First posted
Last updated
Brief Summary
To evaluate the safety and effectiveness of the Cerebral Protection System (model CEP016F, Shanghai Shenqi Medical Technology Co., Ltd.) for capturing and removing thrombotic and tissue debris during transcatheter aortic valve replacement (TAVR).
Frequently Asked Questions
What is Cerebral Embolic Protection Device During TAVR?
Cerebral Embolic Protection Device During TAVR is a clinical trial registered under NCT07627984. Current status: COMPLETED.
What is the status of NCT07627984?
The current status of NCT07627984 (Cerebral Embolic Protection Device During TAVR) is: COMPLETED.
When did Cerebral Embolic Protection Device During TAVR start?
Cerebral Embolic Protection Device During TAVR started on 2023-09-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.